Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication UK00000849765 · Dead

| Application Number | UK00000849765 |
| Status | Dead |
| Owner | Glaxo Group Limited |
| Filed | 1963-05-29 |
| Registered | 1963-05-29 |
| Renewal Due | 2018-05-29 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
UK00000849765 has a current status of Dead.
MARK DESCRIPTION: The Trade Mark consists of a colour applied to one half of the capsule at one end, the other half being colourless and transparent, and two or more colours one of which may be white, being each applied to a substantial number of pellets so that each pellet is of one colour only.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical substances sold in pellet form within capsules.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
This device mark (application number UK00000849765) is a dead trademark on the UK IPO register, filed by Glaxo Group Limited on 29 May 1963, with registration granted on 29 May 1963. It is due to expire on 29 May 2018.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations), specifically covering: MARK DESCRIPTION: The Trade Mark consists of a colour applied to one half of the capsule at one end, the other half being colourless and transparent, and two or more colours one of which may be white, being each applied to a substantial number of pellets so that each pellet is of one colour only.
The trademark is represented by GlaxosmithKline Trade Mark Department.
No — the UK IPO records the status of this trademark as dead.
This trademark is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical substances sold in pellet form within capsules.
The application for this trademark was filed on 29 May 1963 and the trademark was registered on 29 May 1963.
The UK IPO first published / advertised this trademark on 27 June 1979.
The current registration of this trademark is recorded as valid until 29 May 2018, at which point it will need to be renewed to remain in force.
GlaxosmithKline Trade Mark Department is listed as the attorney / representative of record for this trademark on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.